This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Preliminary Report

RAYMOND E. ADAMS, M.D.; ROBERT J. KIRSCHNER, M.D.; IRVING H. LEOPOLD, M.D.

Arch Ophthalmol. 1963;69(1):55-58.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Osmotically active ocular hypotensive agents enable the ophthalmologist to operate with less risk. Although urea is popular currently for this purpose, it is not free of certain disadvantages.

Therefore, mannitol, an osmotic diuretic, was studied clinically to determine if it might be a more acceptable drug for ophthalmic use.

Materials and Methods

The mannitol was supplied as a 20% solution.* The 17 patients included in this study received a total number of 27 separate intravenous infusions of mannitol. They were predominantly uncontrolled glaucoma patients (Table) at Wills Eye Hospital who were refractory to miotics and carbonic anhydrase inhibitors. An intravenous infusion averaging 1.8 gm. (1.2-3.1 gm.) per kilogram of a 20% solution of mannitol was delivered rather rapidly over a period of 30 to 45 minutes. The average volume was usually about 500 cc. The bottles were prewarmed prior to administration to insure that no crystals were present. A . . . [Full Text PDF of this Article]

Author Affiliations
Philadelphia

From Wills Eye Hospital.

Footnotes
Submitted for publication June 13, 1962.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?